Sept. 8, 2004 — The U.S. Food and Drug Administration (FDA) approved in June revisions to safety labeling to advise healthcare professionals of the following changes: estradiol/norethindrone patches ...
MedPage Today on MSN
Compounded Imiquimod Shows Promise for Ocular Surface Cancers
A compounded form of imiquimod, a topical immune response modifier, showed promise as a treatment for ocular surface ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. KOLOA, Hawaii — The use of topical 5-fluorouracil ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback